Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vioxx Settlement Down, Merck Has Three More Government Probes Pending

Executive Summary

Sales rep call notes on Vioxx off-label promotion were a key part of the government’s criminal case against Merck; $950 million settlement includes a new corporate integrity agreement that requires monitoring of call notes.

You may also be interested in...

The Era Of Billion Dollar Pharma Settlements

Abbott Laboratories is the third pharmaceutical company to reach a settlement with the Department of Justice in excess of $1 billion. A look at the deals struck since Eli Lilly began the billion dollar club in 2009 shows the activities the government is investigating and the level of liability that companies face.

Merck’s Morass Of Marketing Probes: DoJ Seeks Data On Three More Drugs

Department of Justice has requested data on AzaSite, which Merck gained in its acquisition of Inspire Pharmaceuticals, Integrilin and Avelox.

GSK’s Deal With DoJ Is Fourth In Eight Years; Exec Liability Uncertain

GlaxoSmithKline PLC’s toughest negotiations this year have been with the federal government.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts